Sessions Information

  • January 7, 2011
    8:30 am - 10:15 am
    Session Type: Section Programs
    Session Capacity: N/A
    Hotel: Hilton San Francisco Union Square
    Room: Franciscan C
    Floor: Ballroom Level

    (Papers to be published in Hastings Science and Technology Law Journal)


    When patents on branded drugs expire and generics enter the market, drug prices tend to drop dramatically.  As a result, getting generic drugs on the shelves is an important part of controlling health care costs. In recent years, however, drug companies have found increasingly creative methods of filing suits, striking deals, and entering into settlements that have the effect of delaying or lessening generic competition.  Are these arrangements problematic under current law?  What role can antitrust law play in monitoring them?


    Business Meeting at Program Conclusion.

Session Speakers
Rutgers Law School

The University of Michigan Law School

New York University School of Law

University of California College of the Law, San Francisco

Columbia Law School

Stanford Law School

Santa Clara University School of Law

Session Fees
  • 6130 Antitrust and Economic Regulation: $0.00